Related Experiment Videos

Detection of activated platelet-derived growth factor receptors in human meningioma

S M Shamah1, J A Alberta, W V Giannobile

  • 1Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA.

Cancer Research
|October 27, 1997
PubMed

Insights

Platelet-derived growth factor (PDGF) signaling is active in human meningiomas. Activated PDGF-beta receptors are constitutively phosphorylated, suggesting a role in brain tumor growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Neuroscience

Background:

  • Platelet-derived growth factor (PDGF) and its beta receptor subunit are expressed in human meningiomas.
  • Autocrine PDGF signaling is implicated in meningioma development.
  • Assessing PDGF receptor activation in tumors is challenging due to tissue complexity.

Purpose of the Study:

  • To investigate the activation state of PDGF-beta receptors in human meningiomas.
  • To develop a tool to detect activated PDGF-beta receptors in tumor tissue.

Main Methods:

  • Raised an antibody targeting phosphorylated tyrosine 751 on the PDGF-beta receptor.
  • Utilized immunoblotting and immunostaining techniques.
  • Analyzed fresh surgical isolates of human meningioma.

Main Results:

  • The PDGF-beta receptor is constitutively phosphorylated at tyrosine 751 in human meningiomas.
  • Phosphotyrosine 751 is a key site for phosphatidylinositol 3'-kinase interaction.
  • This phosphorylation indicates active PDGF signaling pathways.

Conclusions:

  • Activated PDGF-beta receptors are present in human meningiomas.
  • Constitutive PDGF receptor phosphorylation suggests a role in meningioma proliferation.
  • Findings support targeting PDGF signaling in meningioma treatment.

Related Concept Videos